Because CD38 is upstream in this signaling pathway, it seems reasonable to propose that CD38 contributes to these processes and that hearts from CD38−/− mice might also be resistant to cardiac hypertrophy and associated arrhythmias following chronic exposure to β-adrenoreceptor stimulation. Here, CD38 is linked to cardiac hypertrophy.